These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 38473207)

  • 61. XBP1 increases transactivation of somatic mutants of ESR1 and loss of XBP1 reverses endocrine resistance conferred by gain-of-function Y537S ESR1 mutation.
    Barua D; Abbasi B; Gupta A; Gupta S
    Heliyon; 2020 Oct; 6(10):e05217. PubMed ID: 33088967
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Prothymosin alpha selectively enhances estrogen receptor transcriptional activity by interacting with a repressor of estrogen receptor activity.
    Martini PG; Delage-Mourroux R; Kraichely DM; Katzenellenbogen BS
    Mol Cell Biol; 2000 Sep; 20(17):6224-32. PubMed ID: 10938099
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Tumour suppressor TRIM33 targets nuclear β-catenin degradation.
    Xue J; Chen Y; Wu Y; Wang Z; Zhou A; Zhang S; Lin K; Aldape K; Majumder S; Lu Z; Huang S
    Nat Commun; 2015 Feb; 6():6156. PubMed ID: 25639486
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Distinct mechanisms of loss of estrogen receptor alpha gene expression in human breast cancer: methylation of the gene and alteration of trans-acting factors.
    Yoshida T; Eguchi H; Nakachi K; Tanimoto K; Higashi Y; Suemasu K; Iino Y; Morishita Y; Hayashi S
    Carcinogenesis; 2000 Dec; 21(12):2193-201. PubMed ID: 11133808
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Mutation site and context dependent effects of ESR1 mutation in genome-edited breast cancer cell models.
    Bahreini A; Li Z; Wang P; Levine KM; Tasdemir N; Cao L; Weir HM; Puhalla SL; Davidson NE; Stern AM; Chu D; Park BH; Lee AV; Oesterreich S
    Breast Cancer Res; 2017 May; 19(1):60. PubMed ID: 28535794
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Steroid hormone receptors and coregulators in endocrine-resistant and estrogen-independent breast cancer cells.
    Sarvilinna N; Eronen H; Miettinen S; Vienonen A; Ylikomi T
    Int J Cancer; 2006 Feb; 118(4):832-40. PubMed ID: 16152593
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Signal transducer and activator of transcription 5b, c-Src, and epidermal growth factor receptor signaling play integral roles in estrogen-stimulated proliferation of estrogen receptor-positive breast cancer cells.
    Fox EM; Bernaciak TM; Wen J; Weaver AM; Shupnik MA; Silva CM
    Mol Endocrinol; 2008 Aug; 22(8):1781-96. PubMed ID: 18550772
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Amplification of ESR1 may predict resistance to adjuvant tamoxifen in postmenopausal patients with hormone receptor positive breast cancer.
    Nielsen KV; Ejlertsen B; Müller S; Møller S; Rasmussen BB; Balslev E; Lænkholm AV; Christiansen P; Mouridsen HT
    Breast Cancer Res Treat; 2011 Jun; 127(2):345-55. PubMed ID: 20556506
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Molecular basis for estrogen receptor alpha deficiency in BRCA1-linked breast cancer.
    Hosey AM; Gorski JJ; Murray MM; Quinn JE; Chung WY; Stewart GE; James CR; Farragher SM; Mulligan JM; Scott AN; Dervan PA; Johnston PG; Couch FJ; Daly PA; Kay E; McCann A; Mullan PB; Harkin DP
    J Natl Cancer Inst; 2007 Nov; 99(22):1683-94. PubMed ID: 18000219
    [TBL] [Abstract][Full Text] [Related]  

  • 70. ELF5 modulates the estrogen receptor cistrome in breast cancer.
    Piggin CL; Roden DL; Law AMK; Molloy MP; Krisp C; Swarbrick A; Naylor MJ; Kalyuga M; Kaplan W; Oakes SR; Gallego-Ortega D; Clark SJ; Carroll JS; Bartonicek N; Ormandy CJ
    PLoS Genet; 2020 Jan; 16(1):e1008531. PubMed ID: 31895944
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Structural and functional characterization of aromatase, estrogen receptor, and their genes in endocrine-responsive and -resistant breast cancer cells.
    Chan HJ; Petrossian K; Chen S
    J Steroid Biochem Mol Biol; 2016 Jul; 161():73-83. PubMed ID: 26277097
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Endocrine therapy and strategies to overcome therapeutic resistance in breast cancer.
    Mancuso MR; Massarweh SA
    Curr Probl Cancer; 2016; 40(2-4):95-105. PubMed ID: 27839747
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Gli activation by the estrogen receptor in breast cancer cells: Regulation of cancer cell growth by Gli3.
    Massah S; Foo J; Li N; Truong S; Nouri M; Xie L; Prins GS; Buttyan R
    Mol Cell Endocrinol; 2021 Feb; 522():111136. PubMed ID: 33347954
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Targeting tumour re-wiring by triple blockade of mTORC1, epidermal growth factor, and oestrogen receptor signalling pathways in endocrine-resistant breast cancer.
    Ribas R; Pancholi S; Rani A; Schuster E; Guest SK; Nikitorowicz-Buniak J; Simigdala N; Thornhill A; Avogadri-Connors F; Cutler RE; Lalani AS; Dowsett M; Johnston SR; Martin LA
    Breast Cancer Res; 2018 Jun; 20(1):44. PubMed ID: 29880014
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Estrogen receptor-alpha phosphorylated at Ser118 is present at the promoters of estrogen-regulated genes and is not altered due to HER-2 overexpression.
    Weitsman GE; Li L; Skliris GP; Davie JR; Ung K; Niu Y; Curtis-Snell L; Tomes L; Watson PH; Murphy LC
    Cancer Res; 2006 Oct; 66(20):10162-70. PubMed ID: 17047081
    [TBL] [Abstract][Full Text] [Related]  

  • 76. ZNF213 Facilitates ER Alpha Signaling in Breast Cancer Cells.
    Yang H; Lv X; Li X; Mao L; Niu Z; Wang T; Zhuang T; Huang Q
    Front Oncol; 2021; 11():638751. PubMed ID: 33777799
    [TBL] [Abstract][Full Text] [Related]  

  • 77. PSF Promotes ER-Positive Breast Cancer Progression via Posttranscriptional Regulation of
    Mitobe Y; Iino K; Takayama KI; Ikeda K; Suzuki T; Aogi K; Kawabata H; Suzuki Y; Horie-Inoue K; Inoue S
    Cancer Res; 2020 Jun; 80(11):2230-2242. PubMed ID: 32213542
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Regulation of estrogen signaling and breast cancer proliferation by an ubiquitin ligase TRIM56.
    Xue M; Zhang K; Mu K; Xu J; Yang H; Liu Y; Wang B; Wang Z; Li Z; Kong Q; Li X; Wang H; Zhu J; Zhuang T
    Oncogenesis; 2019 Apr; 8(5):30. PubMed ID: 31000690
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Advanced concepts in estrogen receptor biology and breast cancer endocrine resistance: implicated role of growth factor signaling and estrogen receptor coregulators.
    Schiff R; Massarweh SA; Shou J; Bharwani L; Arpino G; Rimawi M; Osborne CK
    Cancer Chemother Pharmacol; 2005 Nov; 56 Suppl 1():10-20. PubMed ID: 16273359
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Human epidermal growth factor receptor 2 status modulates subcellular localization of and interaction with estrogen receptor alpha in breast cancer cells.
    Yang Z; Barnes CJ; Kumar R
    Clin Cancer Res; 2004 Jun; 10(11):3621-8. PubMed ID: 15173068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.